Renal substrates and effect of lipokinetic arylamines on third-factor sodium excretion.
D000818:Animals; D002951:Citrates / Q000097:blood; D003900:Desoxycorticosterone / Q000494:pharmacology; D004285:Dogs; D004983:Ethanolamines / Q000494:pharmacology*; D005230:Fatty Acids, Nonesterified / Q000097:blood; D007545:Isoproterenol / Q000494:pharmacology*; D007668:Kidney / Q000502:physiology*; D007773:Lactates / Q000097:blood; D009318:Natriuresis / Q000187:drug effects*; D009539:Nicotinic Acids / Q000494:pharmacology; D010643:Phenoxybenzamine; D011773:Pyruvates / Q000097:blood; D012965:Sodium Chloride / Q000494:pharmacology; D014667:Vasopressins / Q000494:pharmacology
D002951:Citrates; D004983:Ethanolamines; D005230:Fatty Acids, Nonesterified; D007773:Lactates; D009539:Nicotinic Acids; D011773:Pyruvates; D010643:Phenoxybenzamine; D014667:Vasopressins; D003900:Desoxycorticosterone; D012965:Sodium Chloride; D007545:Isoproterenol